Kathryn Roeder, PhD
Speaking at INSAR 2019 on Thursday, May 2
Kathryn Roeder has developed statistical and machine learning methods in a wide spectrum of areas, including high dimensional data problems. Her work focuses on statistical genetics and the genetic basis of complex disease. Recently her group developed tools for identifying autism risk genes from de novo mutations as well as associated gene networks. She is one of the leaders of the Autism Sequencing Consortium, an international organization dedicated to discovering the genetic etiology of autism. Roeder is the UPMC Professor of Statistics and Life Sciences in the Departments of Statistics & Data Science and Vice Provost for Faculty at Carnegie Mellon University. She received the COPSS Presidents’ Award and the COPSS Snedecor Award for outstanding work in statistical applications, two of the most prestigious awards in her field.
Jason Lerch, PhD
Speaking at INSAR 2019 on Friday, May 3
Jason P. Lerch, Ph.D. is the Director of Preclinical Imaging at the Wellcome Centre for Integrative Neuroimaging (WIN) at the University of Oxford and an Adjunct Scientist at the Mouse Imaging Centre (MICe) of the Hospital for Sick Children and an Associate Professor in Medical Biophysics at the University of Toronto. Jason joined WIN in March of 2019; prior to that he completed his Ph.D. in 2005 in the Department of Neurology and Neurosurgery at McGill University and a post-doctoral fellowship at MICe from 2005-2008 with Dr. Mark Henkelman and Dr. John Sled. He received his B.A. in 1999 in Anthropology and Social Studies of Medicine from McGill University. His Ph.D. research, under the supervision of Dr. Alan Evans, was on in-vivo measurements of cortical thickness from MRI. His current research focus is on detecting neuroanatomical changes due to behavioural and genetic manipulations in tightly controlled mouse models, primarily related to neurodevelopmental disorders, and to relate these findings to sadly not so well controlled human subjects. As an antidote to these academic pursuits, he likes to leave the city and hike in the woods, whenever possible.
Vikram Patel, MBBS, PhD
Speaking at INSAR 2019 on Friday, May 3
Vikram Patel is The Pershing Square Professor of Global Health and Wellcome Trust Principal Research Fellow at the Harvard Medical School. His work spans the areas of mental health problems, child development and adolescent health in the global health context, in particular the use of community resources for assessment, prevention and recovery. He co-founded Sangath, an Indian NGO which has won the MacArthur Foundation’s International Prize for Creative and Effective Institutions and the WHO Public Health Champion of India award. He co-founded the Movement for Global Mental Health and is a Fellow of the UK Academy of Medical Sciences. He was named in the TIME 100 most influential persons of the year in 2015 and is the 2019 laureate of the John Dirk Canada Gairdner Award in Global Health.
Elizabeth Berry-Kravis, MD, PhD
Speaking at INSAR 2019 on Saturday, May 4
Elizabeth Berry-Kravis MD, PhD is a Professor of Pediatrics, Neurological Sciences, and Biochemistry at Rush University Medical Center in Chicago. She established the Fragile X Clinic and Research Program in 1991, through which she provides care to over 600 patients with fragile X syndrome (FXS). She has studied medical issues, epilepsy and psychopharmacology in FXS, and translational research in FXS including outcome measures and biomarkers, natural history, newborn screening, and clinical trials of new targeted treatments in FXS. Her laboratory studies the cellular role of fragile X mental retardation protein (FMRP), relationship between FMRP and clinical function, and optimization of genetic testing methods. More recently she has expanded clinical and translational work to other neurodevelopmental disorders including autism spectrum disorders, and single gene models of ASD in addition to FXS, including Phelan McDermid syndrome, Rett syndrome and Angelman syndrome. She also is working on translational research in rare neurogenetic disorders including Niemann-Pick type C, Battens disease, pantothenate kinase-associated neurodegeneration, and creatine transporter deficiency. She is on Advisory Boards for the FRAXA Research Foundation and the National Fragile X Foundation.